UHOIF(UHOIF)
UHOIF
No analyst ratings available
No analyst price targets available for UHOIF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $210.39B | $221.67B | $231.69B |
| Low | $206.08B | $213.46B | $224.99B |
| High | $212.80B | $229.03B | $236.90B |
| EBITDA Avg | $27.27B | $28.73B | $30.03B |
| Low | $26.71B | $27.67B | $29.16B |
| High | $27.58B | $29.68B | $30.70B |
| EBIT Avg | $17.46B | $18.40B | $19.23B |
| Low | $17.10B | $17.71B | $18.67B |
| High | $17.66B | $19.01B | $19.66B |
| Net Income Avg | $10.86B | $14.96B | $17.30B |
| Low | $10.45B | $14.40B | $16.65B |
| High | $11.18B | $15.40B | $17.80B |
| EPS Avg | $128.87 | $177.51 | $205.27 |
| Low | $124.03 | $170.84 | $197.56 |
| High | $132.64 | $182.70 | $211.28 |
| Analysts (Rev / EPS) | 3 / 1 | 4 / 1 | 3 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $50.63B | $51.23B | $63.69B |
| Low | $50.63B | $51.23B | $63.69B |
| High | $50.63B | $51.23B | $63.69B |
| EBITDA Avg | $6.56B | $6.64B | $8.25B |
| Low | $6.56B | $6.64B | $8.25B |
| High | $6.56B | $6.64B | $8.25B |
| EBIT Avg | $4.20B | $4.25B | $5.29B |
| Low | $4.20B | $4.25B | $5.29B |
| High | $4.20B | $4.25B | $5.29B |
| Net Income Avg | $1.56B | — | — |
| Low | $1.56B | — | — |
| High | $1.56B | — | — |
| EPS Avg | $18.78 | — | — |
| Low | $18.78 | — | — |
| High | $18.78 | — | — |
| Analysts (Rev / EPS) | 1 / 1 | 1 / — | 1 / — |